<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0" xml:base="https://investors.myovant.com/">

    <item>
  <title>keyword_r_and_d_day</title>
  <link>https://raw.githubusercontent.com/Gopichand413/digital-nirvana-ASNG/main/keyword_r_and_d_day.html</link>
  <description>BASEL, Switzerland and LONDON, United Kingdom , Nov. 08, 2021 (GLOBE NEWSWIRE) -- Myovant Sciences  (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced the appointment of Nancy Valente , M.D. as an independent member of the company’s Board of</description>
  <pubDate>Mon, 08 Nov 2021 06:00:00 -0500</pubDate>
    <dc:creator>Myovant Sciences Ltd. News Releases</dc:creator>
    <guid isPermaLink="false">9631</guid>
  </item>
     <item>
  <title>keyword_annual_general_meeting_conference</title>
  <link>https://raw.githubusercontent.com/Gopichand413/digital-nirvana-ASNG/main/annual_general_meeting_conference.html</link>
  <description>BASEL, Switzerland and LONDON, United Kingdom , Nov. 08, 2021 (GLOBE NEWSWIRE) -- Myovant Sciences  (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, today announced the appointment of Nancy Valente , M.D. as an independent member of the company’s Board of</description>
  <pubDate>Mon, 08 Nov 2021 06:00:00 -0500</pubDate>
    <dc:creator>Myovant Sciences Ltd. News Releases</dc:creator>
    <guid isPermaLink="false">9631</guid>
  </item>

  </channel>
</rss>
